Literature DB >> 12642431

Salmeterol (Serevent) asthma trial halted early.

Eric Wooltorton.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12642431      PMCID： PMC154923     

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  9 in total

1.  Should combination therapy with inhaled corticosteroids and long-acting beta2-agonists be prescribed as initial maintenance treatment for asthma?

Authors:  Catherine Lemière; Allan Becker; Louis-Philippe Boulet; Dennis Bowie; André Cartier; Donald Cockroft; Robert Cowie; Pierre Ernst; Mark Fitzgerald; Malcolm Sears; Sheldon Spier
Journal:  CMAJ       Date:  2002-10-29       Impact factor: 8.262

2.  Racial and income disparities in childhood asthma in the United States.

Authors:  Lara J Akinbami; Bonnie J LaFleur; Kenneth C Schoendorf
Journal:  Ambul Pediatr       Date:  2002 Sep-Oct

Review 3.  Canadian Asthma Consensus Report, 1999. Canadian Asthma Consensus Group.

Authors:  L P Boulet; A Becker; D Bérubé; R Beveridge; P Ernst
Journal:  CMAJ       Date:  1999-11-30       Impact factor: 8.262

4.  Risks of salmeterol?

Authors:  F N Finkelstein
Journal:  N Engl J Med       Date:  1994-11-10       Impact factor: 91.245

5.  Bronchodilator treatment in asthma. Study too small to detect increase in deaths.

Authors:  R Bunney
Journal:  BMJ       Date:  1993-06-12

6.  Salmeterol xinafoate vs albuterol in asthma: was race a factor?

Authors:  C O Olopade
Journal:  JAMA       Date:  1994 Nov 23-30       Impact factor: 56.272

7.  Salmeterol for the prevention of high-altitude pulmonary edema.

Authors:  Claudio Sartori; Yves Allemann; Herve Duplain; Mattia Lepori; Marc Egli; Ernst Lipp; Damian Hutter; Pierre Turini; Olivier Hugli; Stephane Cook; Pascal Nicod; Urs Scherrer
Journal:  N Engl J Med       Date:  2002-05-23       Impact factor: 91.245

8.  Serevent nationwide surveillance study: comparison of salmeterol with salbutamol in asthmatic patients who require regular bronchodilator treatment.

Authors:  W Castle; R Fuller; J Hall; J Palmer
Journal:  BMJ       Date:  1993-04-17

9.  Salmeterol: a study by prescription-event monitoring in a UK cohort of 15,407 patients.

Authors:  R D Mann; K Kubota; G Pearce; L Wilton
Journal:  J Clin Epidemiol       Date:  1996-02       Impact factor: 6.437
  9 in total
  11 in total

1.  Long-acting beta2-agonists in asthma: safety concerns.

Authors:  Eric Wooltorton
Journal:  CMAJ       Date:  2005-10-07       Impact factor: 8.262

Review 2.  Overcoming gaps in the management of asthma in older patients: new insights.

Authors:  Pranoy Barua; M Sinead O'Mahony
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

3.  Beta-agonists modulate T-cell functions via direct actions on type 1 and type 2 cells.

Authors:  Matthew J Loza; Susan Foster; Stephen P Peters; Raymond B Penn
Journal:  Blood       Date:  2005-11-08       Impact factor: 22.113

Review 4.  Addition of long-acting beta2-agonists to inhaled steroids versus higher dose inhaled steroids in adults and children with persistent asthma.

Authors:  Francine M Ducharme; Muireann Ni Chroinin; Ilana Greenstone; Toby J Lasserson
Journal:  Cochrane Database Syst Rev       Date:  2010-04-14

Review 5.  Clinical concerns with inhaled beta2-agonists: adult asthma.

Authors:  D W Cockcroft
Journal:  Clin Rev Allergy Immunol       Date:  2006 Oct-Dec       Impact factor: 8.667

Review 6.  Long-acting beta 2-adrenoceptor agonists and exercise-induced asthma: lessons to guide us in the future.

Authors:  Sandra D Anderson; John D Brannan
Journal:  Paediatr Drugs       Date:  2004       Impact factor: 3.022

Review 7.  Potential adverse effects of bronchodilators in the treatment of airways obstruction in older people: recommendations for prescribing.

Authors:  Preeti Gupta; M Sinead O'Mahony
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

Review 8.  Regular treatment with salmeterol for chronic asthma: serious adverse events.

Authors:  Christopher J Cates; Matthew J Cates
Journal:  Cochrane Database Syst Rev       Date:  2008-07-16

Review 9.  Regulation of T cells in airway disease by beta-agonist.

Authors:  Matthew J Loza; Raymond B Penn
Journal:  Front Biosci (Schol Ed)       Date:  2010-06-01

Review 10.  A systematic review of adverse drug events associated with administration of common asthma medications in children.

Authors:  James S Leung; David W Johnson; Arissa J Sperou; Jennifer Crotts; Erik Saude; Lisa Hartling; Antonia Stang
Journal:  PLoS One       Date:  2017-08-09       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.